[Combined sabal and urtica extract vs. finasteride in benign prostatic hyperplasia (Alken stages I to II). Comment on the contribution by J. Sokeland and J. Albrech].
Bartsch
G
G
Dreikom
K
K
Schöntöger
P S
PS
D000368:Aged; D000369:Aged, 80 and over; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000145:classification / Q000188:drug therapy*; D016896:Treatment Outcome; D001748:Urinary Bladder Neck Obstruction / Q000145:classification / Q000188:drug therapy; D014563:Urodynamics / Q000187:drug effects
D004791:Enzyme Inhibitors; D010936:Plant Extracts; D018120:Finasteride
Kombination aus Sabal- und Urticaextrakt vs. Finasterid bei BPH (Stad. I bis II nach Alken). Kommentar zur Arbeit von J. Sökeland und J. Albrech.